Pharmacoepidemiology and benefit/risk management strategies in clinical trials with cell-based combination products

被引：0
|
作者：
Malikova, Marina A. [1 ]
机构：
[1] Boston Univ, Sch Med, Boston Med Ctr, Boston, MA 02215 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
332
引用
收藏
页码：145 / 145
页数：1
相关论文
共 50 条
  • [41] Cell-Based Therapies: Strategies for Regeneration
    Pavlou, Marina
    Reh, Thomas A.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2023, 13 (11):
  • [42] Toward Cardiac Regeneration: Combination of Pluripotent Stem Cell-Based Therapies and Bioengineering Strategies
    Mazzola, Marta
    Di Pasquale, Elisa
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2020, 8
  • [43] Stem/progenitor cell-based transplantation for retinal degeneration: a review of clinical trials
    Yiqi Wang
    Zhimin Tang
    Ping Gu
    Cell Death & Disease, 11
  • [44] Dendritic cell-based immunoregulatory strategies
    Matsue, H
    Kusuhara, M
    Matsue, K
    Takashima, A
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2002, 127 (04) : 251 - 258
  • [45] Cell-based strategies for vascular regeneration
    Zou, Tongqiang
    Fan, Jiabing
    Fartash, Armita
    Liu, Haifeng
    Fan, Yubo
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2016, 104 (05) : 1297 - 1314
  • [46] Stability enhancement of clinical grade multipotent mesenchymal stromal cell-based products
    Mirabel, Clementine
    Puente-Massaguer, Eduard
    del Mazo-Barbara, Anna
    Reyes, Blanca
    Morton, Philip
    Godia, Francesc
    Vives, Joaquim
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [47] Safety issues in cell-based intervention trials
    Dawson, L
    Bateman-House, AS
    Agnew, DM
    Bok, H
    Brock, DW
    Chakravarti, A
    Greene, M
    King, PA
    O'Brien, SJ
    Sachs, DH
    Schill, KE
    Siegel, A
    Solter, D
    Suter, SM
    Verfaillie, CM
    Walters, LB
    Gearhart, JD
    Faden, RR
    FERTILITY AND STERILITY, 2003, 80 (05) : 1077 - 1085
  • [48] Stability enhancement of clinical grade multipotent mesenchymal stromal cell-based products
    Clémentine Mirabel
    Eduard Puente-Massaguer
    Anna del Mazo-Barbara
    Blanca Reyes
    Philip Morton
    Francesc Gòdia
    Joaquim Vives
    Journal of Translational Medicine, 16
  • [49] Risk-Based Quality and Safety Management in Clinical Trials with Combination Devices in Changing Global Regulatory Environment
    Malikova, M.
    Kaliaev, A.
    DRUG SAFETY, 2022, 45 (10) : 1267 - 1267
  • [50] Review of clinical trials and benefit/risk ratio of meloxicam
    Barner, A
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1996, : 29 - 37
12345